Vestia Personal Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$668K Buy
726
+12
+2% +$12.2K 0.31% 42
2025
Q4
$770K Buy
714
+22
+3% +$21K 0.39% 37
2025
Q3
$528K Sell
692
-8
-1% -$5.95K 0.31% 47
2025
Q2
$546K Buy
700
+6
+0.9% +$4.66K 0.37% 44
2025
Q1
$573K Sell
694
-84
-11% -$69.9K 0.45% 38
2024
Q4
$601K Buy
778
+11
+1% +$9.11K 0.49% 37
2024
Q3
$680K Buy
767
+13
+2% +$11.7K 0.64% 31
2024
Q2
$683K Buy
+754
New +$603K 0.73% 29

Other funds holding LLY

Vestia Personal Wealth Advisors's LLY Position: Q1 2026 in Review

Vestia Personal Wealth Advisors increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $12.2K and bringing the position to 726 shares worth $668K. The position accounts for 0.31% of the portfolio, ranked #42.

Vestia Personal Wealth Advisors first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $770K in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Vestia Personal Wealth Advisors held 726 shares of Eli Lilly worth $668K as of Q1 2026.
  • Vestia Personal Wealth Advisors bought 12 Eli Lilly shares in Q1 2026, an estimated $12.2K.
  • Eli Lilly made up 0.31% of Vestia Personal Wealth Advisors's portfolio in Q1 2026, its #42 holding.
  • Vestia Personal Wealth Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • Vestia Personal Wealth Advisors's Eli Lilly position peaked at $770K in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Vestia Personal Wealth Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.